Cardiology

A tailored treatment strategy reduced antibiotic duration by 15 days in patients with left sided infective endocarditis in the POET-II trial, presented during ESC Congress 2026.

A nurse-coordinated, technology-enabled care model for heart failure improved survival without hospitalisation, according to findings presented at the ESC Congress 2026.

Findings from the PRESC1SE-MI trial, presented during ESC Congress 2026, suggest that rapid heart attack testing was as safe as standard pathways but did not shorten emergency department stays.

The first dedicated cardiac rehabilitation ESC guidelines bring together evidence supporting improved heart health, physical function, mental wellbeing, and recovery across multiple cardiovascular conditions.

Rapid heart attack testing matched standard care safety but did not shorten emergency department stay. Read more.

First dedicated ESC guidelines on cardiac rehabilitation highlight wide-ranging benefits for patients with CVD. Read more.

New STAREE trial data presented during ESC Congress 2026 showed atorvastatin reduced major cardiovascular events by 30% in adults aged 70 years and older.

A revised myocardial infarction classification, released during the ESC Congress 2026, replaces numerical labels with three clinical categories supporting more consistent diagnosis.